Genmab — Oktober 2016
-
Solsen - dvs du forventer et Janssen / Merck samarbejde omkring Darzalex / Keytruda i forskellige indikationer?
-
Solsen - jeg mente ikke Keytruda var en konkurrent i MM, men i lungekræft. Men de kan kombineres med succes er det jo nærmere en partner
-
men hvis de....
-
@bikube. Verden forandrer sig enormt hurtigt. Indtil for 3 måneder siden anbefalede stort set alle analytikere BMY pga Opdivos fantastiske evner. Et mislykket første linie studie i lungekræft, og de er bare fuldstændig yt
-
Roches Tecentriq er repræsenteret i 92 trials https://clinicaltrials.gov/ct2/results?term=Tecentriq&pg=5
-
og nævner et nyt studie, men det har nok været nævnt herinde https://clinicaltrials.gov/ct2/show/NCT02927925?term=daratumumab&rank=22
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind